Omongos, Virgilio M.

HRN: 28-43-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2026
CEFTAZIDIME 1GM (VIAL)
01/20/2026
01/26/2026
IV
1g
Q8h
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: